MediWound Ltd. (NASDAQ:MDWD)
| Market Cap | 165.07M-27.1% |
| Revenue (ttm) | 11.86M-40.3% |
| Net Income | -20.18M+28.5% |
| EPS | -1.60+39.3% |
| Shares Out | 12.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 72,434 |
| Open | 13.13 |
| Previous Close | 13.15 |
| Day's Range | 12.81 - 13.23 |
| 52-Week Range | 12.52 - 20.03 |
| Beta | 0.14 |
| Analysts | Buy |
| Price Target | 28.50(+121.79%) |
| Earnings Date | Nov 19, 2026 |
MediWound Ltd. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MDWD stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in MDWD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MDWD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MDWD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MDWD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MDWD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MDWD
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $3.21M |
| IZRLARK Israel Innovative Technology ETF | $1.89M |
| IWOiShares Russell 2000 Growth ETF | $1.21M |
| VTWOVanguard Russell 2000 ETF | $742.22K |
| IWCiShares Micro-Cap ETF | $425.64K |
| IWViShares Russell 3000 ETF | $175.61K |
Estimated from each fund’s disclosed top holdings × AUM
MDWD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MDWD’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score